Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported higher revenues and net profit for the second quarter of 2024. Net income
BMY Earnings: Bristol-Myers Squibb reports higher Q2 revenue and profit
Categories
Health Care
Trxade Health closes business combination with Scienture in $103Mln deal
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, has announced the closing of its business combination with New York-based
AbbVie Q2 2024 adj. profit drops despite higher revenues; results beat
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Thursday announced second-quarter 2024 financial results, reporting a decline in adjusted earnings and an increase
Envoy Medical is well-positioned to gain market share in hearing implant space: CEO
Envoy Medical (NASDAQ: COCH) is a leader in hearing solutions, offering innovative hearing technologies and advanced hearing implants. Its fully implanted hearing
Earnings Summary: IQVIA reports higher revenue and adj. profit for Q2 2024
IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported
ISRG Earnings: Intuitive Surgical Q2 profit jumps on strong revenue growth
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the second quarter of 2024, reporting higher revenues and adjusted
Abbott Laboratories (ABT) Q2 2024 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported second quarter 2024 earnings results today. Net sales increased 4% year-over-year to $10.4 billion. Net earnings decreased
Johnson & Johnson (JNJ) Q2 2024 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2024 earnings results today. Reported sales increased 4.3% year-over-year to $22.4 billion. Operational sales
Infographic: How UnitedHealth Group (UNH) performed in Q2 2024
UnitedHealth Group (NYSE: UNH) reported second quarter 2024 earnings results today. Revenues increased to $98.9 billion from $92.9 billion a year ago.
Intuitive Surgical likely to report strong revenue, profit growth for Q2 2024
Intuitive Surgical, Inc. (NASDAQ: ISRG) is expected to report its second-quarter earnings next week, amid expectations for strong revenue and profit growth.
Johnson & Johnson to publish Q2 report next week. Here’s what to look for
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) has constantly strengthened its portfolio over the years by acquiring new businesses, investing in new
UNH Earnings Preview: What to expect when UnitedHealth reports Q2 results
Health insurer UnitedHealth Group (NYSE: UNH) stands out in the healthcare space for its unique business model covering a broad range of
Everything you need to know about OS Therapies’ upcoming IPO
There has been a strong uptick in IPO activity this year compared to 2023 when the market witnessed a slowdown. In the
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the first quarter of 2024. The company
Alumis looks to raise $300 million in IPO. Here’s what you need to know
Technology and healthcare companies are continuing to dominate the IPO market, which is witnessing a significant increase in activity compared to 2023.
WBA Earnings Preview: Will Walgreens’ Q3 report bring cheer to investors?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable retail environment.
Tempus AI gears up for IPO. Here’s everything you need to know
The IPO market witnessed stronger activity so far this year compared to the corresponding period last year, with a marked increase in
Ocean Biomedical (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a new-generation biotechnology firm that works to accelerate the development of new therapies by partnering with
Key metrics from Medtronic’s (MDT) Q4 2024 earnings results
Medtronic plc (NYSE: MDT) reported fourth quarter 2024 earnings results today. Worldwide revenue was $8.6 billion, up 0.5% on a reported basis
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a
Earnings Summary: Organon reports financial results for Q1 2024
Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the first quarter of 2024. First-quarter revenue